Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Anastos

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS)K Anastos, L A Kalish, H Palacio, et al.
AIDS (London, England)|October 31, 2001
The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected womenH Minkoff, L Ahdieh, L S Massad, et al.
HIV Medicine|May 11, 2016
Bone quality assessed using quantitative ultrasound at the distal radius does not differ in antiretroviral therapy-naïve HIV-positive and HIV-negative Rwandan womenE Mutimura, Q Shi, D R Hoover, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Opportunistic infection prophylaxis in the women's interagency HIV study (WIHS)M Augenbraun, P Tarwater, R Greenblatt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000
HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1A Kovacs, L S Chan, Z C Chen, et al.
AIDS Research and Human Retroviruses|August 24, 2000
Factors associated with incident self-reported AIDS among women enrolled in the women's interagency HIV study (WIHS). WIHS Collaboratorive Study GroupN A Hessol, K Anastos, A M Levine, et al.
AIDS (London, England)|June 6, 2000
Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV studyJ G Feldman, D N Burns, S J Gange, et al.
AIDS Care|September 27, 2003
Dissatisfaction with medical care among women with HIV: dimensions and associated factorsJ K Burke, J A Cook, M H Cohen, et al.
American Journal of Epidemiology|November 25, 2000
Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virusL Ahdieh, S J Gange, R Greenblatt, et al.
AIDS Care|December 13, 2005
Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive womenJ A Cook, D Grey, J Burke-Miller, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS)K Anastos, L A Kalish, H Palacio, et al.
AIDS (London, England)|October 31, 2001
The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected womenH Minkoff, L Ahdieh, L S Massad, et al.
HIV Medicine|May 11, 2016
Bone quality assessed using quantitative ultrasound at the distal radius does not differ in antiretroviral therapy-naïve HIV-positive and HIV-negative Rwandan womenE Mutimura, Q Shi, D R Hoover, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Opportunistic infection prophylaxis in the women's interagency HIV study (WIHS)M Augenbraun, P Tarwater, R Greenblatt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000
HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1A Kovacs, L S Chan, Z C Chen, et al.
AIDS Research and Human Retroviruses|August 24, 2000
Factors associated with incident self-reported AIDS among women enrolled in the women's interagency HIV study (WIHS). WIHS Collaboratorive Study GroupN A Hessol, K Anastos, A M Levine, et al.
AIDS (London, England)|June 6, 2000
Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV studyJ G Feldman, D N Burns, S J Gange, et al.
AIDS Care|September 27, 2003
Dissatisfaction with medical care among women with HIV: dimensions and associated factorsJ K Burke, J A Cook, M H Cohen, et al.
American Journal of Epidemiology|November 25, 2000
Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virusL Ahdieh, S J Gange, R Greenblatt, et al.
AIDS Care|December 13, 2005
Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive womenJ A Cook, D Grey, J Burke-Miller, et al.
Pageof 5